R3R 01
Alternative Names: R3R-01Latest Information Update: 02 Sep 2022
At a glance
- Originator River 3 Renal
- Class Small molecules; Urologics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Focal segmental glomerulosclerosis; Hereditary nephritis
Most Recent Events
- 15 Jun 2022 Phase-II clinical trials in Focal segmental glomerulosclerosis (In children, In adolescents, In adults, In the elderly) in USA, Belgium and Netherlands (PO) (NCT05267262) (EudraCT2021-004192-13)
- 15 Jun 2022 Phase-II clinical trials in Hereditary nephritis (In children, In adolescents, In adults, In the elderly) in USA, Belgium and Netherlands (PO) (NCT05267262) (EudraCT2021-004192-13)
- 10 Mar 2022 Preclinical for Focal segmental glomerulosclerosis in USA (PO)